calendar
5,340 catalysts · 5,063 phase readout · 2,335 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion
next 91 dayslessmore
MonWedFri
5,340 catalysts · 5,063 phase readout · 2,335 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion
no tagged catalysts yet
Sponsor: NYU Langone Health. Phase: PHASE4. Conditions: Metastatic Melanoma, Advanced Melanoma
Sponsor: Centre Jean Perrin. Phase: NA. Conditions: Locally Advanced Head and Neck Carcinoma
Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: PHASE2. Conditions: Bile Duct Cancer
Sponsor: Chang Gung Memorial Hospital. Phase: PHASE2. Conditions: Hepatocellular Carcinoma Non-resectable
Sponsor: University of Sao Paulo General Hospital. Phase: NA. Conditions: Intubation, Intratracheal, Airway Management, Video Laryngoscope, Cost Effectiveness
Sponsor: Danderyd Hospital. Phase: . Conditions: Coronary Artery Disease, Arterial Stiffness, Blood Pressure, AORTIC VALVE DISEASES, Mitral Valve Stenosis and/or Insufficiency, Heart Failure, Pulmonary Disease, Chronic Obstructive (COPD), Steatohepatitis, Inflammation Biomarkers, Lipid Profile, Oral Microbiota, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Associated-dysfunction Steatohepatitis (MASH)
Sponsor: University of Regina. Phase: PHASE1. Conditions: Healthy
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: Amyotrophic Lateral Sclerosis
Sponsor: Hospital Clinic of Barcelona. Phase: NA. Conditions: Prostate Cancer, Radical Prostatectomy
Sponsor: Fondazione Don Carlo Gnocchi ETS. Phase: . Conditions: Lower Limb Amputation, Slip Perturbations, Fall Risk
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris. Phase: . Conditions: Patients for Whom an Angiomammogram Examination is Requested Whether Its Indication
Sponsor: Pfizer. Phase: PHASE2. Conditions: Elranatamab, Myeloma, Multiple Myeloma, Relapsed Multiple Myeloma, Refractory Multiple Myeloma, PF-06863135, BCMA, Bispecific, Bispecific Antibody, BCMA-CD3 Bispecific, MagnetisMM-8
Sponsor: SparingVision. Phase: PHASE1. Conditions: Retinitis Pigmentosa
Sponsor: Duke University. Phase: NA. Conditions: Infections
Sponsor: Hôpital NOVO. Phase: . Conditions: Plastic Surgery
Sponsor: Vanderbilt University Medical Center. Phase: PHASE2. Conditions: Status Asthmaticus
Sponsor: University Hospital, Lille. Phase: . Conditions: Chronic Rhinosinusitis With Nasal Polyps
Sponsor: Boston Scientific Corporation. Phase: . Conditions: Chronic Pain
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: NA. Conditions: Brain Cancer
Sponsor: Murdoch Childrens Research Institute. Phase: NA. Conditions: Food Allergy, Food Allergy in Infants
Sponsor: Alexion Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Neuromyelitis Optica Spectrum Disorder
Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Chronic Pain, Opioid Use, Cannabis
Sponsor: Azienda Ulss 2 Marca Trevigiana. Phase: . Conditions: Asthma, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Sponsor: Sun Yat-sen University. Phase: PHASE1. Conditions: Relapsed or Refractory Peripheral T Cell Lymphoma, NKTCL
Sponsor: COVID-19 Prevention Network. Phase: . Conditions: Tuberculosis
Sponsor: Synbiotic Health. Phase: NA. Conditions: Healthy Aging, Anti Aging
Sponsor: Mesoblast, Inc.. Phase: PHASE2. Conditions: Type 1 Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Insulin-Dependent, Juvenile Diabetes
Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Trachoma, Eye Diseases, Trichiasis
Sponsor: BioNTech SE. Phase: PHASE1. Conditions: Metastatic Colorectal Cancer
Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Prematurity
Sponsor: University of Pittsburgh. Phase: NA. Conditions: Child Behavior Problem, Attention Deficit and Disruptive Behavior Disorders
Sponsor: Seoul National University Hospital. Phase: NA. Conditions: Acute Kidney Injury
Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Acellular Dermal Matrix, Alveolar Mucosa
Sponsor: University of Minnesota. Phase: PHASE2. Conditions: Gaucher Disease Type 1
Sponsor: HIV Prevention Trials Network. Phase: NA. Conditions: HIV Infections, Drug Use, Opioid Use, Opioid-use Disorder
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: . Conditions: Multiple Sclerosis
Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Chronic Kidney Diseases
Sponsor: Karabuk University. Phase: NA. Conditions: Volleyball, Performance, Power
Sponsor: ABLE Human Motion S.L.. Phase: NA. Conditions: Acquired Brain Injury (Including Stroke)
Sponsor: Sabine Mueller, MD, PhD. Phase: PHASE1. Conditions: Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent
Sponsor: Washington State University. Phase: PHASE2. Conditions: Alcohol Use Disorder (AUD)
Sponsor: Regeneron Pharmaceuticals. Phase: PHASE1. Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)
Sponsor: Queen Mary University of London. Phase: . Conditions: Infective Endocarditis, Endocarditis, Endocarditis, Bacterial
Sponsor: Rush University Medical Center. Phase: PHASE2. Conditions: Anterior Cruciate Ligament Reconstruction, Total Hip Arthroplasty (THA), Total Knee Arthroplasty, Hip Arthroscopy
Sponsor: Zhejiang Cancer Hospital. Phase: PHASE2. Conditions: IBI363 + Chemotherapy
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Filariasis, Helminthiasis, Parasitic Infection, Mansonelliasis, Onchocerciasis
Sponsor: RemeGen Co., Ltd.. Phase: PHASE1. Conditions: Non-Small Cell Lung Cancer
Sponsor: Elizabeth J Franzmann. Phase: PHASE2. Conditions: Oropharyngeal Dysplasia, Oral Cavity Dysplasia, Oral Carcinoma in Situ
Sponsor: Chinese PLA General Hospital. Phase: . Conditions: Migraine
Sponsor: Castagna Antonella. Phase: . Conditions: Hiv, HIV Infections, AIDS